pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›grant
grant
save

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The Novel Role and Mechanism of RBM33 in Leukemogenesis

March 1, 2026updated 5mo ago
community read0 votes

CA grant. $473,946. PI: Zhijian Qian

view source ↗
Data sources
nih reporter
last refreshed 5mo ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — DYRK1A inhibitors, GLP1 Receptor Agonists and Immunomodulation for Beta Cell ...Feb 15, 2026
  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — An exosome-based liquid biopsy assay for the non-invasive early detection of ...Mar 16, 2026
  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Molecular Mechanisms Governing Non-canonical miR-146a BiogenesisFeb 5, 2026
  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — A novel pentavalent circular RNA-based EBV vaccineApr 1, 2026
  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — Role and regulation of methylarginine effector TDRD3 in T cell immunityApr 8, 2026
  • grantBECKMAN RESEARCH INSTITUTE/CITY OF HOPE — The role of ALKBH5-mediated RNA demethylation in the maintenance of genomic s...Jan 13, 2026

🐶 often sniffed alongside

top 8
  • tagOncology2 co-mentions · 2 sources
  • tagAML1 co-mentions · 1 sources
  • drugMETHOTREXATE1 co-mentions · 1 sources
  • tagType 1 Diabetes1 co-mentions · 1 sources
  • tagType 2 Diabetes1 co-mentions · 1 sources
  • tagVaccine1 co-mentions · 1 sources
  • tagDLBCL1 co-mentions · 1 sources
  • tagEndocrinology & Metabolism1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?